Financials
- Market Capitalization 70.59 M
- Employee 49
- Founded 2015
- CEO N/A
- Website www.pliantrx.com
- Headquarter Delaware, United States
- FIGI BBG00C8083N4
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4152 | IBIO iBio, Inc. - Common Stock | 1.45 USD | -3.97% | -12.12% | -15.20% | -36.96% | 72.03 M USD | ||
| 4155 | XBIT XBiotech Inc. - Common Stock | 2.33 USD | +1.75% | -2.10% | -1.69% | -19.66% | 71.04 M USD | ||
| 4166 | IMA ImageneBio, Inc. - Common Stock | 6.11 USD | +3.38% | +2.52% | +5.34% | -66.06% | 68.92 M USD | ||
| 4171 | PMVP PMV Pharmaceuticals, Inc. - Common Stock | 1.28 USD | +3.23% | +4.07% | +15.32% | -3.76% | 68.26 M USD |
Frequently asked questions about Pliant Therapeutics, Inc. - Common Stock
What is the Pliant Therapeutics, Inc. - Common Stock stock price today?
The current price of Pliant Therapeutics, Inc. - Common Stock (PLRX) is 1.1400000000000001. Over the past 24 hours, the stock has changed by +1.79%. Follow the PLRX chart for real-time price dynamics.
What is the stock ticker of Pliant Therapeutics, Inc. - Common Stock?
Pliant Therapeutics, Inc. - Common Stock trades under the ticker PLRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Pliant Therapeutics, Inc. - Common Stock stock going up?
PLRX has changed by -0.87% over the last week, -1.72% over the last month, and -21.38% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Pliant Therapeutics, Inc. - Common Stock net income for the last quarter?
Pliant Therapeutics, Inc. - Common Stock reported net income of -20.04 M for the last quarter. The previous quarter showed -23.58 M, which means net income changed by +15.00%.
How many employees does Pliant Therapeutics, Inc. - Common Stock have?
As of the latest available data, Pliant Therapeutics, Inc. - Common Stock has 49 employees. Workforce size can provide additional context about the company's scale and operations.
What is Pliant Therapeutics, Inc. - Common Stock EBITDA?
Pliant Therapeutics, Inc. - Common Stock EBITDA is -21.41 M, and its EBITDA margin is -22.78 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Pliant Therapeutics, Inc. - Common Stock stock?
You can buy Pliant Therapeutics, Inc. - Common Stock (PLRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Pliant Therapeutics, Inc. - Common Stock stock?
Investing in Pliant Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PLRX chart and related analysis on metatrader.com as part of your research.